GoodRx Holdings, Inc.
GDRXNASDAQHealthcare● Active
$2.68
+$0.03(+0.94%)
Market Cap$927234113
P/E Ratio—
52W High$5.81
52W Low$1.77
GoodRx Holdings, Inc. (GDRX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GDRX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.80B | $0.79B | $0.75B | $0.77B | $0.75B |
| Cost of Revenue | $0.06B | $0.05B | $0.07B | $0.07B | $0.05B |
| Gross Profit | $0.74B | $0.74B | $0.68B | $0.70B | $0.70B |
| Gross Margin %(computed) | 92.77% | 93.91% | 91.08% | 91.51% | 93.73% |
| Operating Expenses | |||||
| R&D Expenses | $0.12B | $0.12B | $0.14B | $0.14B | $0.13B |
| G&A Expenses | $0.11B | $0.12B | $0.13B | $0.14B | $0.15B |
| Total Operating Expenses | $0.65B | $0.68B | $0.71B | $0.70B | $0.69B |
| Operating Income | $0.09B | $0.07B | ($0.03B) | $0.00B | $0.01B |
| Operating Margin %(computed) | 10.98% | 8.31% | -3.60% | 0.23% | 1.80% |
| Interest Income | $0.01B | $0.02B | $0.03B | $0.01B | $0.00B |
| Interest Expense | $0.04B | $0.05B | $0.06B | $0.03B | $0.02B |
| Income Before Tax | $0.06B | $0.03B | ($0.06B) | ($0.02B) | ($0.01B) |
| Income Tax Expense | $0.03B | $0.02B | ($0.05B) | $0.01B | $0.02B |
| Net Income | $0.03B | $0.02B | ($0.01B) | ($0.03B) | ($0.03B) |
| Net Margin %(computed) | 3.82% | 2.07% | -1.18% | -4.28% | -3.39% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.09 | $0.04 | $-0.02 | $-0.08 | $-0.06 |
| Wtd Avg Shares | 0.36B | 0.39B | 0.41B | 0.41B | 0.41B |
| EBITDA | $0.18B | $0.15B | $0.11B | $0.07B | $0.05B |
| EBITDA Margin %(computed) | 23.14% | 19.43% | 14.50% | 8.50% | 6.44% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more GoodRx Holdings, Inc. data
About GoodRx Holdings, Inc. (GDRX) Income Statement
GoodRx Holdings, Inc. (GDRX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GDRX reported revenue of $0.80B, gross profit of $0.74B (gross margin 92.77%), and net income of $0.03B — a net profit margin of 3.82%.
Frequently asked questions
GDRX · 4 questionsGoodRx Holdings, Inc. (GDRX) reported revenue of $0.80B for 2025, up 0.6% year-over-year.
GDRX revenueGDRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08